Cardiol Therapeutics Inc. (CRDL) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CRDL Revenue Growth
CRDL Revenue Analysis (2017–2024)
As of May 8, 2026, Cardiol Therapeutics Inc. (CRDL) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, CRDL's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $62,267 in 2021.
When compared to Healthcare sector peers including ARWR (+14.1% YoY), TELA (+12.2% YoY), and MDGL (+256.8% YoY). Compare CRDL vs ARWR →
CRDL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CRDLCurrent | $0 | - | - | - | |
 ARWR | $829M | +14.1% | +56.6% | 11.9% | |
 TELA | $69M | +12.2% | +35.0% | -49.2% | |
 MDGL | $958M | +256.8% | - | -31.3% |
CRDL Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-40,276,651 | - |
| 2023 | $0 | - | $-187,383 | - | $-22,473,162 | - |
| 2022 | $0 | -100.0% | $-162,226 | - | $-30,493,477 | - |
| 2021 | $62K | - | $-111,997 | -179.9% | $-30,568,391 | -49092.4% |
| 2020 | $0 | - | $-180,171 | - | $-16,240,550 | - |
| 2019 | $0 | - | $-116,114 | - | $-10,894,751 | - |
| 2018 | $0 | - | $-91,492 | - | $-7,390,433 | - |
| 2017 | $0 | - | $-53,341 | - | $-1,589,312 | - |
See CRDL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRDL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRDL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRDL — Frequently Asked Questions
Quick answers to the most common questions about buying CRDL stock.
Is CRDL's revenue growth accelerating or slowing?
CRDL TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CRDL's long-term revenue growth rate?
Cardiol Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CRDL's revenue distributed by segment?
CRDL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.